Acadian Asset Management
DBTX

Acadian Asset Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Acadian Asset Management’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,240
Closed -$5K – 1905
2022
Q2 		$5K Sell
1,240
-3,043
-71% -$7.19K ﹤0.01% 1653
2022
Q1 		$13K Hold
4,283
– – ﹤0.01% 1592
2021
Q4 		$19K Buy
+4,283
New +$29.5K ﹤0.01% 1618

Other funds holding DBTX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Acadian Asset Management's DBTX Position: Q3 2022 in Review

Acadian Asset Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2022, closing a stake of 1,240 shares — an estimated $5K sold.

Acadian Asset Management first reported a position in DBTX in Q4 2021 and held it in 3 quarters. The position peaked at $19K in Q4 2021. 40 funds tracked by Wall St. Rank hold DBTX as of Q3 2022.

  • Acadian Asset Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Acadian Asset Management sold 1,240 Decibel Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $5K.
  • Acadian Asset Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Acadian Asset Management's Decibel Therapeutics, Inc. Common Stock position peaked at $19K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Acadian Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.